LCCL protein complex formation in Plasmodium is critically dependent on LAP1. by Tremp, AZ et al.
 1 
LCCL protein complex formation in Plasmodium is critically dependent on LAP1 
 
 
Annie Z. Tremp1, Vikram Sharma2, Victoria Carter1, Edwin Lasonder2 and Johannes T. Dessens1 
 
1Pathogen Molecular Biology Department, Faculty of Infectious and Tropical Diseases, London School of 
Hygiene &Tropical Medicine, Keppel Street, London WC1E 7HT, UK; 2School of Biomedical and 
Healthcare Sciences, Plymouth University, Drake Circus, Plymouth PL4 8AA, UK. 
 
 
 
Correspondence should be addressed to Johannes T. Dessens, LSHTM, Keppel Street, WC1E 7HT, London, 
UK, Tel.: +442079272865; Fax: +442076374314; E-mail: Johannes.Dessens@lshtm.ac.uk 
 
Graphical abstract 
This is an accepted manuscript of an article published by Elsevier in Molecular & Biochemical Parasitology
(accepted April 12th 2017) available at: http://dx.doi.org/10.1016/j.molbiopara.2017.04.005
=====================================================================================
 2 
 
  
GRAPHICAL ABSTRACT
 3 
Highlights 
 The six LAPs in Plasmodium berghei form a protein complex in ookinetes 
 
 Complex formation begins in macrogametocytes with LAP1, LAP2 and LAP3 interactions  
 
 LAP1 plays a key role in recruitment of LAP4, LAP5 and LAP6 to the complex 
 
 The LAP complex displays different strength interactions between components 
 
Successful sporogony of Plasmodium berghei in vector mosquitoes requires expression of a family of six 
modular proteins named LCCL lectin domain adhesive-like proteins (LAPs). The LAPs share a 
subcellular localization in the crystalloid, a unique parasite organelle that forms during ookinete 
development. Here, LAP interactions in P. berghei were studied using a series of parasite lines stably 
expressing reporter-tagged LAPs combined with affinity purification and high accuracy label free 
quantitative mass spectrometry. Our results show that abundant complexes containing LAP1, LAP2 
and LAP3 are formed in gametocytes through high avidity interactions. Following fertilization, LAP4, 
LAP5 and LAP6 are recruited to this complex, a process that is facilitated by LAP1 chiefly through its 
scavenger receptor cysteine-rich modules. These collective findings provide new insight into the 
temporal and molecular dynamics of protein complex formation that lead up to, and are required for, 
crystalloid biogenesis and downstream sporozoite transmission of malaria parasites. 
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LCCL proteins form a family of unique modular proteins restricted to apicomplexan parasites [1]. The proteins 
obtained their name from possessing one or more copies of the ‘LCCL' domain, a conserved protein module 
that was first identified in the founding proteins Limulus clotting factor C; cochlear protein Coch-5b2; and 
lung gestation protein Lgl1 [2]. Six LCCL protein family members have been identified in Plasmodium, which 
in P. berghei are mostly referred to as LCCL lectin adhesive-like protein (LAP) 1 to 6 [3] (Fig. 1). They have 
a complex and unique architecture typified by possessing multiple domains implicated in protein, lipid and 
carbohydrate binding [1, 4] (Fig. 1). LAP5 does not possess a predicted LCCL module and is included in the 
family by virtue of its otherwise similar structure to LAP3 (Fig. 1). Disruption of lap genes in P. berghei, 
either individually or in pairs, gives rise to very similar loss-of-function phenotypes characterized by a failure 
of the oocyst to produce infective sporozoites [5-10].  
 A significant advance in our understanding of the LAPs came with the discovery that they are targeted 
to the crystalloids and are required for crystalloid formation [5, 10, 11]. First described in 1962 [12], 
crystalloids are transient subcellular organelles that are implicated in malaria transmission by virtue of their 
exclusive presence in ookinetes and young oocysts (reviewed in [13]). The organelles are conserved in human, 
monkey, rodent and bird malaria species, and they appear in electron microscopy as clusters of small vesicles 
[14]. Whilst P. berghei ookinetes contain on average two crystalloids, only a single large crystalloid is found 
in the oocyst indicating that crystalloid biogenesis completes after ookinete-to-oocyst transition [10]. The 
inability to form crystalloids appears to be a shared feature of LAP knockout parasites, as is their inability to 
form sporozoites, thus providing a functional link between crystalloid formation and successful sporogonic 
development. A mutant parasite line expressing LAP3 lacking its LCCL domain and turning it into a LAP5-
like protein was shown to have delayed crystalloid formation [10], further pointing to the involvement of the 
LAPs in crystalloid genesis.  
 The similar loss-of-function phenotypes of the LAPs in P. berghei suggest that they operate as a 
protein complex. Indeed, LAP orthologues in the human malaria parasite P. falciparum were shown to co-
immunoprecipitate with specific antibodies, supporting formation of a LAP complex [15]. Furthermore, in 
vitro binding assays with recombinant, bacterially expressed proteins corresponding to various LAP portions 
identified putative interactions between LAP1 and all other LAPs except LAP5; between LAP2 and LAP3; 
and between LAP2 and LAP5 in P. falciparum [15]. In this paper we report a complementary in vivo approach 
to investigate LAP interactions in the rodent malaria parasite P. berghei, using a series of existing and newly 
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generated genetically modified parasite lines stably expressing LAPs fused to green fluorescent protein (GFP), 
combined with GFP affinity purification and label-free quantitative mass spectrometry (LFQ MS). 
 We began by testing whether we could successfully pull down GFP-tagged LAPs from purified 
parasites with magnetic beads conjugated to anti-GFP antibodies (see supplemental Materials and Methods 
section). Gametocyte pull down samples of parasite line LAP3/GFP that expresses LAP3 fused to a carboxy-
terminal GFP [11] were subjected to SDS-PAGE alongside corresponding samples from wild-type parasites, 
followed by protein staining (Fig. 2A). This visualized several bands specific to the LAP3/GFP sample, one 
of which corresponded to the target protein (LAP3::GFP) as demonstrated by western blot using anti-GFP 
antibodies (Fig. 2B). These results indicated that the anti-GFP antibody-bound magnetic microbeads are 
successful in isolating the GFP-tagged target protein as well as proteins bound to it. Indeed, subsequent MS-
based proteomic analysis (see supplemental Materials and Methods section) revealed that the GFP pull-down 
samples harvested from the purified LAP3/GFP gametocytes reproducibly contained LAP1, LAP2 and LAP3 
as the most abundant proteins (Table 1 and supplemental Table S1). This is consistent with the reported protein 
expression of LAP1, LAP2 and LAP3 in P. berghei macrogametocytes [5, 11]. Pull down from purified 
LAP3/GFP ookinetes, which express the full LAP repertoire [16], gave the same result, as did equivalent pull 
down samples from parasite line LAP1/GFP (originally called PbSR/EGFP [5]) (Tables 1, S1). As expected, 
LAPs were not pulled down from LAP3-KO or LAP1-KO parasites by the same method (Tables 1, S1), 
providing further evidence that the pull downs are specific. These collective results indicate that LAP1, LAP2 
and LAP3 have high avidity interactions with each other, but not with the other LAPs.  
 To further investigate LAP family member interactions, we carried out similar pull down experiments 
with parasite lines LAP4/GFP, LAP5/GFP and LAP6/GFP [16]. Transcripts of lap4, lap5 and lap6 are 
translationally repressed in gametocytes and not expressed as protein until after fertilization [16], therefore 
ookinete samples were used. Pull-down samples from purified LAP4/GFP or LAP5/GFP ookinetes contained 
high levels of LAP4 and LAP5, but little or no LAP1, LAP2, LAP3 or LAP6 (Tables 1, S1), showing that 
LAP4 and LAP5 interact with high avidity with each other, but not with the other LAPs. In pull-down samples 
of LAP6/GFP ookinetes, only LAP6 was detected in discernible amounts (Tables 1, S1), indicating that LAP6 
does not bind to its family members with high avidity. 
 Based on domain topologies, LAP4 is considered a structural paralogue of LAP2, and LAP5 is a 
structural paralogue of LAP3 (Fig. S1). The interaction observed between LAP4 and LAP5 could therefore 
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resemble that between LAP2 and LAP3. To test whether LAP2 could interact directly with LAP3, as shown 
for LAP4 and LAP5 (Tables 1, S1), we used a parasite line which expresses GFP-tagged LAP3 in a LAP1 
knockout background [17]. GFP pull down samples from these parasites contained no LAP1, as expected, but 
still contained abundant LAP2 and LAP3 (Tables 1, S1). This shows that LAP2 and LAP3 interact with high 
avidity in the absence of LAP1. 
 The failure to pull down LAP4, LAP5 and LAP6 with GFP-tagged LAP1 or LAP3, and vice versa 
(Tables 1, S1), could reflect weak interactions that were lost during the cell lysis step before pull down. To 
test this hypothesis, ookinetes purified from parasite line LAP3/GFP were crosslinked in vivo by formaldehyde 
treatment before cell lysis (see supplemental Materials and Methods section). Formaldehyde is one of the 
shortest available cross-linkers is (2.3–2.7 Å) and low concentrations (0.4–2%) and short reaction times 
(minutes instead of hours) allow its utilization as a crosslinker to analyze protein-protein interactions [18]. 
Indeed, crosslinking resulted in the pull down of all six LAPs (Tables 1, S1), indicating that LAP4, LAP5 and 
LAP6 are part of the LAP complex albeit through weaker interactions, and join the LAP1/2/3 subcomplex 
after fertilization. 
 Given the structural and interaction similarities between the LAP2/3 and LAP4/5 pairs, we next 
hypothesized that the recruitment of the other LAPs to the complex could be mediated by LAP1. This was 
tested using ookinetes from the mutant parasite line that expresses LAP3::GFP in a LAP1 knockout 
background [17] combined with in vivo crosslinking. Using this approach, LAP4 and LAP5 were pulled down 
with markedly reduced efficacy relative to LAP2 and LAP3, while LAP6 failed to co-purify altogether (Tables 
1, S1). These results indicate that LAP1 plays a key role in recruiting LAP4, LAP5 and LAP6 to the LAP 
complex.  
 To further dissect the role of LAP1 in these interactions, we carried out pull downs from ookinete 
lysates (after crosslinking) with parasite line LAP1SRCR/GFP expressing LAP1::GFP without its two SRCR 
domains [5]. Removal of the SRCR domains of LAP1 results in a LAP1 knockout phenotype characterized by 
a lack of crystalloid biogenesis and sporozoite formation [5].  Pull down with this parasite gave a similar 
outcome as using parasites lacking LAP1 altogether: low amounts of LAP4 and LAP5 were pulled down 
relative to LAP1, LAP2 and LAP3, while LAP6 failed to co-purify (Tables 1, S1), indicating that the SRCR 
domains play a central role in LAP complex formation. The ability to efficiently pull down LAP2 and LAP3 
in this experiment shows that the mutant LAP1 protein without the SRCR modules retains interaction with 
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LAP2 and LAP3. LAP1 is the only protein in the genus Plasmodium that contains SRCR domains and, 
importantly, these domains are unique among all SRCR domains in possessing two additional cysteine residues 
in one of hypervariable loop-out regions between sheets 4 and 5 [6]. In CD6, hypervariable regions in the 
SRCR domain are involved in substrate interaction and specificity [19]. The unique cysteines contained in this 
hypervariable region could thus be involved in LAP1 interaction and function, for example by forming new 
intra-domain disulfides, or by interacting with other domains within LAP1 or other family members. 
 As an internal control for the LAP1SRCR/GFP parasite we also generated a new parasite line named 
LAP1PTX/GFP, which expresses LAP1::GFP without its pentaxin (PTX) domain (see supplemental 
Materials and Methods section and supplemental Fig. S1). Like LAP1SRCR/GFP parasites, 
LAP1PTX/GFP parasites failed to form crystalloids and generated oocysts, the large majority of which failed 
to produce sporozoites (Fig. S1). However, compared to LAP1SRCR/GFP, pull down from LAP1PTX/GFP 
ookinetes yielded considerably higher levels of LAP4, LAP5 and LAP6, albeit the amounts were reduced 
compared to ookinetes expressing the full-length LAP1 (Tables 1, S1). These observations indicate that the 
SRCR and PTX modules of LAP1 contribute differentially to the formation of the complete LAP complex. 
Moreover, the very similar phenotypes of these LAP1 mutant parasites indicate that the relative amounts of 
individual LAPs within the complex is equally important for its function.  
Ablation or mutation of LAP1 did not appear to have a significant effect on the relative levels of LAP2 
and LAP3, as opposed to LAP4, LAP5 and LAP6 (Tables 1 and S1). The reduced levels of LAP4, LAP5 and 
LAP6 in these pull-down samples could reflect a reduced ability to bind to the gametocyte-specific LAP 
subcomplex. It is also possible that the stability of these proteins was adversely affected, possibly a direct 
consequence of sub-optimal binding to the other LAPs resulting in conformational changes and misfolding. In 
this context it is important to note that in P. falciparum ablation of certain LAPs can adversely affect the level 
of other LAPs, a phenomenon that was called co-dependent expression [15]. Whatever the precise underlying 
mechanism, LAP1 clearly has a key role in formation of a complete and fully functional LAP complex. 
  Pull down samples from ookinetes of parasite line LAP3LCCL/GFP, which expresses a version of 
LAP3::GFP that lacks its LCCL domain (previously described as PbLAP3/LCCL-KO [10]) contained high 
levels of LAP1, LAP2 and LAP3 similar to full-length LAP3/GFP pull-downs (Tables 1, S1). Likewise, in 
vivo crosslinked ookinete samples of parasite line LAP3LCCL/GFP gave rise to co-purification of all LAP 
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family members similar to full-length LAP3/GFP pull-downs (Tables 1, S1). These combined data show that 
the LCCL domain of LAP3 is not required for the formation of the LAP1/2/3 sub-complex or indeed the 
complete LAP complex, indicating that this LCCL domain is not significantly involved in the LAP 
interactions. This is consistent with the observation that mature ookinetes of this parasite can form crystalloids 
and give rise to normal sporozoite development and transmission [10]. However, crystalloid biogenesis in 
LAP3LCCL/GFP ookinetes is retarded [10], which suggests that the LCCL domain of LAP3 does 
nonetheless have a subtle role within the LAP complex enhancing downstream crystalloid genesis.   
 Whilst recognizing the limitations of in vitro interaction studies with bacterially expressed proteins 
compared to parasite-expressed equivalents (e.g. with regards to protein conformation), the LAP interactions 
reported for P. falciparum [15] are broadly consistent with this study and point to a conservation of LAP 
interactions between the two Plasmodium species. This concept is strongly supported by the highly conserved 
and unique architectures of the LAP family members. It is important to note that in P. falciparum all six LAP 
homologues are expressed as protein in gametocytes [20], in contrast to P. berghei where transcripts of lap4, 
lap5 and lap6 are translationally repressed in gametocytes resulting in their protein expression post-
fertilization [16]. The different strength interactions between different LAP combinations as identified in this 
study could be a mechanism to ensure that complex formation of the LAP homologues in P. falciparum follows 
a similar order of events to that in P. berghei despite all LAPs being present at the same time. Furthermore, 
gametocyte development in P. falciparum takes much longer than in P. berghei, increasing the likelihood that 
staggered LAP expression and complex assembly as shown here for P. berghei could occur in the human 
malaria parasite during gametocytogenesis.  
 Unravelling the molecular interactions of the LAP complex is important, because its disruption could 
be a way to achieve malaria transmission-blockade. LAPs are already expressed in blood stage gametocytes, 
particularly in P. falciparum, and accordingly the LAP complex could potentially be targeted in the human 
host before the parasite enters the mosquito. Furthermore, LAP knockout and mutational studies show that 
disruption of the LAP complex does not affect the parasite until after oocyst development, so the ookinete and 
oocyst burden in the insects are not reduced, yet the insects are not infective. Targeting the LAP complex 
therefore has the advantages that it would not rely on the uptake of the active compounds by the vector 
mosquito, and it would minimize risk of enhancing mosquito fitness as a consequence of lowering the parasite 
load in the insect, which could enhance vectorial capacity [21]. The identification of LAP1, and particularly 
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of its SRCR domains, as critical sites for LAP interaction and complex formation will aid future design and 
identification of small molecule inhibitors of these processes and downstream parasite transmission.  
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Figure legends 
 
Fig. 1 Schematic diagram of Plasmodium LAP1-LAP6 (PlasmoDB IDs shown on the right hand side). All 
proteins possess a predicted N-terminal ER signal peptide (red). A variety of modules are shown with 
significant homologies to known protein domains. Black: Limulus coagulation factor C, Coch-5b2 and Lgl1 
(LCCL) domain (Pfam03815, Smart00603); Light green: Polycystin-1, Lipoxygenase, Alpha-Toxin (PLAT) 
domain (Pfam01477, Smart00308); Light blue: scavenger receptor cysteine-rich (SRCR) domain (Pfam00530, 
Smart00202); Pink: pentaxin (PTX)/Laminin-G domain (Pfam00354, Smart00159); Orange: ricin-type beta 
trefoil lectin domain (Pfam00161, Smart00458); Red: coagulation factor 5/8 carboxy-terminal/discoidin 
domain (Pfam00754, Smart00231); Yellow: fibrillar collagen (COLFI) carboxy-terminal domain (Pfam01410, 
Smart00038)); Dark blue: Levanase-like domain; Purple: anthrax protective antigen domain (Pfam07691); 
Dark green: fibronectin type II domain (Pfam00040, Smart00059); Grey: apicomplexan-specific cysteine-rich 
domain.  
 
Fig. 2 Immunoaffinity pull-down of LAP complexes from P. berghei gametocytes with anti-GFP antibody-
coated magnetic beads. A: Coomassie brilliant blue staining shows specific pull down of the LAP3::GFP target 
protein and several other proteins (arrow heads). Lanes 1+2: wildtype; lanes 3+4; LAP3/GFP; lanes 1+3: 
before pull down; lanes 2+4: after pull down.  B: Western blot using anti-GFP antibodies shows enrichment 
of the LAP3::GFP target protein. Nonspecific (ns) antibody binding is indicated. Molecular weight markers in 
kDa are shown (M). 
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Table 1. Relative abundance of LAPs in GFP pull down samples from Plasmodium berghei parasite lines.  
____________________________________________________________________________________________________________________________ 
 
Parasite line1 
 
gametocyte 
 
ookinete 
 
crosslinked 
Relative percentage LFQ intensity (number of unique peptides) 
_____________________________________________________________ 
LAP1 LAP2 LAP3 LAP4 LAP5 LAP6 
____________________________________________________________________________________________________________________________ 
LAP3/GFP2 +   229 (45) 236 (55) 100 (35) 0 (0) 0 (0) 0 (0) 
LAP3/GFP +   277 (51) 93 (46) 100 (33) 0 (0) 0 (0) 0 (0) 
LAP3-KO3 +   0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
LAP3/GFP  +  249 (52) 261 (69) 100 (43) 0.2 (2) 0 (0) 0 (0) 
LAP3/GFP  +  452 (52) 439 (73) 100 (41) 0.6 (3) 0 (1) 0 (0) 
LAP3-KO  +  0 (1) 0 (2) 0 (1) 0 (0) 0 (0) 0 (0) 
LAP1/GFP4  +  1087 (43) 316 (18) 100 (12) 0 (0) 0 (0) 0 (0) 
LAP1-KO5  +  0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
          
LAP4/GFP6  +  0 (0) 0 (0) 0 (0) 100 (14) 169 (11) 1.2 (3) 
LAP4/GFP  +  0 (0) 0 (0) 0 (0) 100 (8) 18 (7) 0 (0) 
LAP5/GFP6  +  0 (0) 0 (0) 0 (0) 652 (17) 100 (9) 0 (0) 
LAP5/GFP  +  0 (0) 0 (0) 0 (0) 254 (17) 100 (6) 0 (0) 
LAP6/GFP5  +  0 (0) 0 (0) 0 (0) 0 (0) 0.8 (1) 100 (14) 
LAP6/GFP  +  0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 100 (4) 
          
LAP3/GFP (LAP1-KO)7  +  0 (0) 550 (27) 100 (18) 0 (0) 0 (0) 0 (0) 
LAP3/GFP (LAP1-KO)  +  0 (0) 74 (12) 100 (12) 0 (0) 0 (0) 0 (0) 
          
LAP3/GFP  + + 270 (44) 282 (54) 100 (29) 222 (37) 151 (23) 15 (11) 
LAP3/GFP  + + 152 (52) 391 (84) 100 (50) 80 (35) 83 (24) 2.1 (12) 
LAP3/GFP (LAP1-KO)  + + 0 (0) 248 (56) 100 (32) 2.5 (4) 1.0 (3) 0 (0) 
LAP1SRCR/GFP4  + + 54 (27) 322 (59) 100 (37) 2.9 (5) 1.0 (5) 0 (0) 
LAP1PTX/GFP8  + + 112 (24) 216 (42) 100 (25) 56 (18) 18 (9) 1.8 (2) 
          
LAP3LCCL/GFP3  +  207 (59) 309 (79) 100 (42) 0 (0) 0 (1) 0 (0) 
LAP3LCCL/GFP  + + 172 (49) 352 (75) 100 (32) 67 (35) 42 (24) 4.0 (11) 
____________________________________________________________________________________________________________________________ 
1 Duplicate samples correspond to independent biological replicates. 
2 [11]. 
3 [10]. 
4 [5]. 
5 [6]. 
6 [16]. 
7 [17]. 
8 This paper (Fig. S1). 
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Supplemental Figure S1 
 
 
Fig. S1 Genotypic and phenotypic analyses of parasite line LAP1DPTX/GFP. A: Structure of wildtype (WT) 
and modified lap1 alleles in parasite lines LAP1/GFP and LAP1DPTX/GFP after double crossover 
homologous recombination. The lap1 gene is indicated with coding sequence (wide grey bars) and 5’ and 3’ 
untranslated regions (UTRs) (narrow grey bars). Also indicated are the PTX domain (black); the GFP 
module; the TgDHFR selectable marker gene cassette and primers used for diagnostic PCR amplification 
(P1-P5). Primer P2 sequence is not present within the targeting vector. Diagnostic PCR product sizes are 
indicated with arrowed lines and numbers (kb). B: Diagnostic PCR across the 3'-integration site with primers 
P1 (TCGTGGGCTACGTCCCGCAC) and P2 (CGCCTTCACGCTGATGT) amplify an approximately 1kb 
product in parasite lines LAP1DPTX/GFP as well as in parasites expressing full-length GFP-tagged LAP1, 
showing integration of the selectable marker into the lap1 locus. Diagnostic PCR with primers P3 
(AAACATTTTTCGAGCATAATATG) and P4 (ATGAGGGCCCCTAAGCTTAAGCGTTTCAAAAAGG-
TAAATGA) amplify a 1.4kb product from both WT parasites and parasites expressing full-length GFP-
tagged LAP1, while they amplify a 0.9kb fragment from parasite line LAP1DPTX/GFP, confirming absence 
of the PTX domain-encoding sequence in the latter parasite. Diagnostic PCR with primers P5 
(GCATGATGAGGATAATAATAAAACT) and P2 amplify an approximately 1.5kb fragment only from the 
parental WT parasites, confirming absence of the unmodified lap1 allele in the transgenic parasite lines. The 
same primer pair instead amplify much larger products in the transgenic parasite lines (approximately 7.7kb 
and 7.2kb in LAP1/GFP and LAP1DPTX/GFP, respectively), because of the presence of additional 
sequences between the primer annealing sites. C: Confocal brightfield and fluorescence images of a typical 
ookinete of parasite line LAP1DPTX/GFP, showing absence of focal spots corresponding to crystalloids. D: 
Transmission electron micrograph of a typical LAP1DPTX/GFP ookinete thin section, showing absence of 
crystalloids. E: Brightfield image of an Anopheles stephensi midgut section at 2 weeks post-infection with 
parasite line LAP1DPTX/GFP, showing non-sporulating oocysts. 
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Table S1. Relative abundance of LAPs in GFP pull down samples from Plasmodium berghei parasite lines.  
____________________________________________________________________________________________________________________________ 
 
Parasite line 
 
gametocyte 
 
ookinete 
 
crosslinked 
LFQ intensity  
_____________________________________________________________ 
LAP1 LAP2 LAP3 LAP4 LAP5 LAP6 
____________________________________________________________________________________________________________________________ 
LAP3/GFP +   76001000 78178000 33188000 0 0 0 
LAP3/GFP +   57151000 19142000 20605000 0 0 0 
LAP3-KO +   0 0 0 0 0 0 
LAP3/GFP  +  141100000 147900000 56656000 84248 0 0 
LAP3/GFP  +  208560000 203210000 46269000 278540 0 0 
LAP3-KO  +  0 0 0 0 0 0 
LAP1/GFP  +  77120000 22450000 7093800 0 0 0 
LAP1-KO  +  0 0 0 0 0 0 
          
LAP4/GFP  +  0 0 0 14160000 23920000 317420 
LAP4/GFP  +  0 0 0 41938000 7493700 0 
LAP5/GFP  +  0 0 0 23050000 3532700 0 
LAP5/GFP  +  0 0 0 12929000 5087900 0 
LAP6/GFP  +  0 0 0 0 32435 4041100 
LAP6/GFP  +  0 0 0 0 0 783480 
          
LAP3/GFP (LAP1-KO)  +  0 107610000 19640000 0 0 0 
LAP3/GFP (LAP1-KO)  +  0 2968900 4020400 0 0 0 
          
LAP3/GFP  + + 80922000 84715000 30014000 66883000 45241000 4486800 
LAP3/GFP  + + 132900000 341900000 87438000 70305000 72480000 1849900 
LAP3/GFP (LAP1-KO)  + + 0 77154000 31079000 783880 252280 0 
LAP1DSRCR/GFP  + + 31100000 183590000 57184000 1670300 554360 0 
LAP1DPTX/GFP  + + 30212000 58171000 26993000 15206000 4767100 493400 
          
LAP3DLCCL/GFP  +  163040000 243100000 78705000 0 0 0 
LAP3DLCCL/GFP  + + 69466000 142360000 40358000 27266000 16924000 1624200 
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